Pharmaceutical – Page 2 – Stockmark.IT

NHS Launches Antibiotic Subscription Scheme with Pharmaceutical Industry

Pfizer continues to test a once-aday weight loss pill

Arecor Therapeutics PLC: A Rising Star in Diabetes and Obesity Innovations

After Macron’s charm offensive, UK pharmaceutical giants commit £430m to France

FDA Grants Rare Pediatric Disease Designation to Imaging Biometrics’ Lead Drug Candidate IB-003

Shield Therapeutics Reports Nearly Tripled Revenues in 2023

Sir John Bell, tsar of life sciences, believes that London is not the best place to raise funds.

Ireland’s life sciences industry is healthy, leaving the UK sickly.

Novo Nordisk shares reach record highs as obesity drug boom drives share prices up

Debt-laden Haleon kisses goodbye to ChapStick

Syntara’s $10M Raise: Fueling Drug Development

Walgreen, Boots’ owner, explores London listing for high-street chain

Weight loss drug manufacturer plots a ‘buy Now, Pay Later’ offer

Tonix Pharmaceuticals’ CEO Reveals Next-Generation COVID Vaccine Technology chosen for key program

Boots is the latest foreign takeover to fail of a British retailer

Merck opens a £1bn London research center with a plea for government support to industry

Scandinavians are euphoric and terrified by the’miracle weight loss drug’

Pharma companies under scrutiny for using blue blood from horseshoe crabs